Metabolism

📚 01 General Pediatrics • 🎯 101 High-Yield MCQs • Nelson 22nd Edition Standard

Glycogen Storage Diseases (GSDs) & Carbohydrate Metabolism

  • Hers Disease (GSD VI): ((MET001)): Caused by deficiency of liver glycogen phosphorylase, resulting in hepatomegaly and hypoglycemia. - Distractors: Muscle phosphorylase deficiency causes McArdle disease (GSD V) (exercise intolerance, cramps, myoglobinuria).
  • Pompe Disease (GSD II): ((MET002)): Caused by deficiency of lysosomal acid $\alpha$-1,4-glucosidase (acid maltase). Presents with massive cardiomegaly, skeletal muscle weakness, and hypotonia. Treated with enzyme replacement therapy (alglucosidase alfa). - Distractors: Glucose-6-phosphatase deficiency causes Von Gierke disease (GSD I) (severe fasting hypoglycemia, lactic acidosis, hyperuricemia).
  • Tarui Disease (GSD VII): ((MET005)): Caused by deficiency of muscle phosphofructokinase (PFK).
  • Classic Galactosemia: ((((MET003)) · ((MET026)))): Caused by deficiency of galactose-1-phosphate uridyltransferase (GALT). Presents with vomiting, jaundice, hepatomegaly, and susceptibility to E. coli sepsis. - Mandatory Action: Newborn screening sample must be collected before any RBC transfusion to avoid a false-negative result due to replacement of deficient erythrocytes ((MET026)). - Distractors: Galactokinase deficiency causes isolated cataracts without systemic toxicity.

Lysosomal Storage Disorders (LSDs)

  • Fabry Disease: ((((MET004)) · ((MET008)))): The only X-linked recessive lysosomal storage disorder (all others are autosomal recessive). Caused by deficiency of $\alpha$-galactosidase A. Features angiokeratomas, hypohidrosis, corneal/lens opacities, acroparesthesias, and renal/cardiac vascular disease.
  • Tay-Sachs Disease: ((MET007)): Caused by deficiency of $\beta$-hexosaminidase A leading to GM2 ganglioside accumulation. Presents with neuroregression, hyperacusis (exaggerated startle), and cherry-red macula.
  • Krabbe Disease: ((MET009)): Globoid cell leukodystrophy caused by deficiency of galactocerebrosidase. Histology reveals multinucleated globoid cells in the white matter, leading to rapid demyelination.
  • Metachromatic Leukodystrophy: ((MET010)): Caused by deficiency of arylsulfatase A, leading to sulfatide accumulation and progressive central/peripheral demyelination.
  • Niemann-Pick Disease Type A: ((MET031)): Caused by deficiency of acid sphingomyelinase. Presents with neonatal massive hepatosplenomegaly, coarse facies, hypotonia, neurodegeneration, and a cherry-red spot.
  • Wolman Disease: ((MET032)): Caused by lysosomal acid lipase deficiency. Features severe hepatomegaly, failure to thrive, and pathognomonic adrenal calcifications.
  • I-Cell Disease (Mucolipidosis II): ((MET033)): Caused by defective mannose-6-phosphate tagging. Presents with severe corneal clouding, coarse facies (gargoylism), and skeletal deformities (dysostosis multiplex) in newborns.
  • Gaucher Disease Type 2: ((MET034)): Caused by deficiency of $\beta$-glucocerebrosidase, presenting with acute neonatal neurodegeneration and massive hepatosplenomegaly.
  • GM1 Gangliosidosis: ((MET006)): Caused by deficiency of $\beta$-galactosidase. Features psychomotor retardation, hepatosplenomegaly, and angiokeratomas (not peripheral neuropathy).
  • Morquio Disease (MPS IV): ((MET022)): Caused by deficiency of N-acetylgalactosamine-6-sulfatase or $\beta$-galactosidase.

Amino Acid & Organic Acid Disorders

  • Phenylketonuria (PKU): ((((MET014)) · ((MET015)) · ((MET021)))): Caused by deficiency of phenylalanine hydroxylase (requires cofactor tetrahydrobiopterin / BH4). Features musty/mousy urine odor caused by phenylacetic acid, fair skin, developmental delay, and seizures.
  • Alkaptonuria: ((((MET017)) · ((MET021)))): Caused by deficiency of homogentisate 1,2-dioxygenase (homogentisate oxidase). Homogentisic acid accumulates, causing urine to turn dark brown/black upon standing.
  • Tyrosinemia Type 1: ((MET018)): Caused by deficiency of fumarylacetoacetate hydrolase (FAH). Diagnostic hallmark is elevated serum/urine succinylacetone.
  • Maple Syrup Urine Disease (MSUD): ((((MET025)) · ((MET027)))): Caused by a defect in the branched-chain $\alpha$-ketoacid dehydrogenase (BCKDH) complex, impairing metabolism of leucine, isoleucine, and valine. Features a burnt sugar/maple syrup urine odor and neurotoxicity from leucine. Some variants are responsive to high-dose thiamine (Vitamin B1) ((MET027)).
  • Isovaleric Acidemia: ((MET020)): Caused by isovaleryl-CoA dehydrogenase deficiency. Features a characteristic sweaty feet odor.
  • Propionic Acidemia: ((MET028)): Caused by propionyl-CoA carboxylase deficiency, a biotin-dependent enzyme. Management includes biotin supplementation.
  • Hartnup Disease: ((MET019)): Neutral amino acid transport defect. Unique among aminoacidurias in that mental retardation is not a feature; presents with intermittent ataxia and pellagra-like photosensitive rash.

Lipid, Peroxisomal, & Other Metabolic Disorders

  • Familial Hypercholesterolemia: ((MET011)): Autosomal dominant (AD) disorder caused by mutations in the LDL receptor gene (LDLR). Presents with markedly elevated LDL, tendon xanthomas, and premature cardiovascular disease.
  • Lesch-Nyhan Syndrome: ((MET012)): X-linked recessive disorder caused by deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT1). Features severe hyperuricemia, self-mutilating behavior, and dystonia.
  • Reye Syndrome: ((MET013)): Acute encephalopathy and hepatic dysfunction following viral infection and aspirin use, categorized biochemically as a secondary pyrimidine nucleotide disorder due to mitochondrial toxicity.
  • Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHADD): ((MET029)): Fatty acid oxidation defect presenting with neonatal cardiomyopathy, hepatomegaly, and hypoketotic hypoglycemia, with elevated long-chain hydroxyacylcarnitines.
  • Zellweger Spectrum Disorders: ((MET030)): Caused by peroxisome biogenesis defects (most commonly PEX1 mutations). Accumulation of very-long-chain fatty acids (VLCFAs) and phytanic acid, presenting with severe neonatal hypotonia, high forehead, and renal cysts.
  • Congenital Disorders of Glycosylation (CDGs): ((MET035)): Most common form is PMM2-CDG (CDG-Ia), caused by mutations in the PMM2 gene. Features severe hypotonia, cerebellar hypoplasia, and characteristic suprapubic/buttock fat pads.
  • Acute Intermittent Porphyria (AIP): ((((MET023)) · ((MET024)))): Rate-limiting step of heme synthesis is catalyzed by mitochondrial delta-aminolevulinic acid (ALA) synthase ((MET023)). AIP presents with neurovisceral attacks and characteristic hyponatremia (frequently secondary to SIADH) ((MET024)).

Inborn Errors of Metabolism: Amino Acid & Organic Acid Disorders

  • Aminoacidopathies vs. Other IEMs: ((MET036)): An infant with poor feeding, vomiting, lethargy, seizures, and a positive family history but normal blood glucose, normal ammonia, normal acid-base status, normal anion gap, and absent urine ketones points to an aminoacidopathy (unlike organic acidemias which feature metabolic acidosis with an increased anion gap, urea cycle defects which cause severe hyperammonemia with respiratory alkalosis, or galactosemia which features hypoglycemia and hepatomegaly).
  • Phenylketonuria (PKU): ((((MET037)) · ((MET038)))): Caused by deficiency of phenylalanine hydroxylase resulting in elevated plasma phenylalanine, decreased tyrosine (making tyrosine an essential amino acid), and increased urinary phenylpyruvate and phenylacetate responsible for the musty odor. Classic presentation includes fair hair/skin (hypopigmentation), eczema, developmental delay, seizures, and progressive intellectual decline. Treatment / Contraindication: Maternal PKU requires strict dietary control before conception; failure to do so causes severe teratogenesis (microcephaly, intellectual disability, congenital heart disease) ((MET039)).
  • Alkaptonuria: ((MET047)): Caused by deficiency of homogentisic acid oxidase in phenylalanine-tyrosine catabolism. Leads to accumulation of homogentisic acid causing ochronosis (dark pigmentation of ear cartilage and sclera), urine that turns dark on standing, and calcification/narrowing of intervertebral discs.
  • Hartnup Disease: ((MET048)): Autosomal recessive defect in neutral amino acid transport (including tryptophan) across renal and intestinal epithelia. Presents with intermittent ataxia, cutaneous photosensitivity, and a pellagra-like rash over sun-exposed areas. Cognitive development is typically normal.
  • Multiple Carboxylase Deficiency: ((MET049)): Biotin-dependent enzyme defect presenting with seizures, lethargy, metabolic acidosis with high anion gap, ketonuria, normal ammonia, and a characteristic scaly erythematous rash over face and perineum with a "tomcat urine" odor.

Lysosomal Storage & Peroxisomal Disorders

  • GM2 Gangliosidosis (Tay-Sachs Disease): ((MET040)): Deficiency of $\beta$-hexosaminidase A leading to lysosomal accumulation of GM2 gangliosides in the CNS. Presents at 4–5 months of age with exaggerated startle response (hyperacusis), macrocephaly (without hydrocephalus), decreased eye contact, and cherry-red spot on the macula.
  • Niemann-Pick Disease: ((MET041)): Deficiency of acid sphingomyelinase (SMPD1 gene) leading to sphingomyelin accumulation. Features hepatosplenomegaly, developmental regression, interstitial lung disease, and a cherry-red macular spot.
  • Gaucher Disease: ((MET042)): Caused by acid $\beta$-glucosidase (GBA) deficiency. Presents with recurrent bone pain, easy bruising, cytopenias, and progressive splenomegaly; bone marrow aspirate shows macrophages with wrinkled tissue paper–like cytoplasm. Type 1 is treated with enzyme replacement (imiglucerase), whereas Type 2 presents with early neurodegeneration (trismus, opisthotonos).
  • Krabbe Disease: ((MET056)): Autosomal recessive deficiency of galactocerebrosidase (GALC gene) causing galactosylceramide accumulation in myelin. Presents with early-onset irritability, hypertonia, optic atrophy, peripheral demyelination, and multinucleated globoid cells in white matter.
  • Metachromatic Leukodystrophy (MLD): ((MET058)): Lysosomal storage disorder due to deficiency of arylsulfatase A, causing sulfatide accumulation. Features progressive motor regression, ataxia, optic atrophy, hypotonia with absent deep tendon reflexes, and central/peripheral demyelination.
  • X-Linked Adrenoleukodystrophy (ALD): ((MET057)): Peroxisomal disorder caused by ABCD1 gene mutation impairing very long-chain fatty acid (VLCFA) transport. Manifests with cognitive decline, behavioral changes, spasticity, and primary adrenal insufficiency. Diagnosis is confirmed by elevated plasma very long-chain fatty acids (VLCFAs).
  • Refsum Disease: ((MET065)): Peroxisomal disorder caused by defective alpha-oxidation of branched-chain fatty acids, leading to accumulation of phytanic acid. Presents with retinitis pigmentosa, cerebellar ataxia, peripheral neuropathy, anosmia, and ichthyosis.

Glycogen Storage Diseases (GSD)

  • Von Gierke Disease (GSD Type I): ((((MET043)) · ((MET052)) · ((MET054)))): Deficiency of glucose-6-phosphatase. Features severe fasting hypoglycemia that fails to respond to glucagon or epinephrine, massive hepatomegaly with doll-like facies, lactic acidosis, hyperuricemia, and hyperlipidemia. Management: Maintain continuous glucose supply via frequent daytime complex carbohydrate meals and uncooked cornstarch. Fructose and galactose are contraindicated as they worsen lactic acidosis and glycogen accumulation.
  • Pompe Disease (GSD Type II): ((((MET044)) · ((SYS053)))): Deficiency of acid $\alpha$-1,4-glucosidase (acid maltase). Presents as a floppy baby with severe hypotonia, massive cardiomegaly (hypertrophic cardiomyopathy with short PR interval and large QRS complexes), macroglossia, and elevated creatine kinase. Treated with enzyme replacement therapy; cardiac transplantation is ineffective.
  • Cori Disease (GSD Type III): ((MET045)): Debrancher enzyme (amylo-1,6-glucosidase) deficiency leading to accumulation of limit dextrins. Resembles Type I GSD with hepatomegaly and fasting hypoglycemia, but distinguished by normal blood lactate and uric acid, prominent transaminase elevation, and fasting ketosis.
  • McArdle Disease (GSD Type V): ((((MET051)) · ((MET055)))): Muscle glycogen phosphorylase deficiency. Presents with exercise intolerance, muscle cramps, fatigue, and myoglobinuria (dark cola-colored urine) following strenuous exercise. Characterized by chronically elevated baseline serum CK and a failure of blood lactate to rise on a forearm ischemic exercise test.

Carbohydrate & Lipid Intolerance Disorders

  • Galactosemia: ((((MET059)) · ((MET060)) · ((MET062)) · ((MET064)))): Deficiency of galactose-1-phosphate uridyl transferase (GALT). Presents in neonates after milk feeding with direct hyperbilirubinemia, hepatomegaly, severe hypoglycemia, cataracts, and reducing substances positive in urine with a negative glucose dipstick. Patients have a strikingly increased susceptibility to Escherichia coli sepsis.
  • Hereditary Fructose Intolerance: ((((MET061)) · ((MET063)))): Deficiency of Aldolase B. Asymptomatic until weaning (introduction of fruit juices/sucrose). Presents with vomiting, lethargy, jaundice, hepatomegaly, hypophosphatemia, and hypoglycemia.
  • Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency: ((MET066)): Most common $\beta$-oxidation defect. Presents between 3 months and 5 years of age with fasting-triggered hypoketotic hypoglycemia, elevated transaminases, and no cardiomyopathy.
  • Ketotic Hypoglycemia: ((MET067)): Most common cause of hypoglycemia in toddlers (ages 1–4, resolving by 6–8 years). Presents with early-morning lethargy, low insulin, hypoglycemia, and positive urinary ketones. Managed by avoiding fasting >8–10 hours and providing complex bedtime carbohydrates.
  • Smith-Lemli-Opitz Syndrome (SLOS): ((MET068)): Cholesterol biosynthesis defect causing microcephaly, retromicrognathia, developmental delay, and hypospadias (epispadias is not a feature).
  • Familial Hypercholesterolemia: ((MET069)): Characterized by markedly elevated LDL cholesterol. Initial management in children consists of a low-fat diet before considering pharmacotherapy (e.g., statins, typically reserved for age $\ge$10 years with severe LDL elevations or strong family history).
  • Tangier Disease: ((MET070)): Autosomal recessive disorder characterized by very low HDL-C levels and pathognomonic large, orange-colored tonsils along with hepatosplenomegaly and peripheral neuropathy due to reticuloendothelial cholesterol accumulation.

Inborn Errors of Metabolism: Lysosomal Storage & Lipid Disorders

  • Wolman's Disease: ((MET071)): Rare autosomal recessive lysosomal storage disorder caused by complete deficiency of lysosomal acid lipase. Manifests with hepatosplenomegaly, jaundice, steatorrhea, and failure to thrive, leading to death by 1 year. Classic abdominal X-ray finding: bilateral adrenal calcifications at birth. Distinguish from neonatal adrenal hemorrhage, which is usually unilateral, associated with birth trauma/hypoxia, and lacks hepatosplenomegaly, jaundice, or anemia.
  • Gaucher Disease: ((MET092)): Lysosomal storage disorder caused by deficiency of beta-glucocerebrosidase, leading to accumulation of glucocerebroside in macrophages. Bone marrow aspiration reveals characteristic Gaucher cells (20-100 μm in diameter with a "wrinkled tissue paper" cytoplasm, strongly periodic acid–Schiff [PAS] positive). Presents with bone pain, hepatosplenomegaly, and cytopenias. Contrast with Niemann-Pick disease (acid sphingomyelinase deficiency), which presents with foamy macrophages, hepatosplenomegaly, and cherry-red spots.
  • Fabry Disease: ((MET099)): X-linked inborn error of glycosphingolipid metabolism due to alpha-galactosidase A deficiency. Characterized by angiokeratomas (tiny, dark red/blue-black, non-blanching papules distributed in a "bathing trunk" pattern)[], hypohidrosis, corneal/lenticular opacities, and acroparesthesias. ---

Purine, Pyrimidine, and Porphyrin Disorders

  • Lesch-Nyhan Disease: ((MET072)): X-linked recessive disorder caused by deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT). Features hyperuricemia, intellectual disability, choreoathetosis, spasticity, dysarthria, and compulsive self-injurious behaviors (lip and finger biting) beginning with tooth eruption. Normal BUN and ammonia differentiate it from urea cycle defects.
  • Orotic Aciduria: ((MET073)): Pyrimidine nucleotide disorder caused by a hereditary defect in uridine monophosphate synthase (UMPS) (bifunctional enzyme with OPRT and OMP decarboxylase activities). Presents with failure to thrive, megaloblastic anemia unresponsive to vitamin B12 and folate, delayed milestones, and markedly elevated urinary orotic acid with normal serum ammonia.
  • Acute Intermittent Porphyria (AIP): ((MET080)): Caused by deficient activity of porphobilinogen deaminase (PBGD / hydroxymethylbilane synthase). Suspect in adolescents presenting with neurovisceral symptoms (abdominal pain, autonomic instability like hypertension and tachycardia, urinary retention) and port wine-colored urine on standing. ---

Amino Acidopathies & Porphyria/Organic Acidemias

  • Phenylketonuria (PKU): ((((MET075)) · ((MET100)))): Autosomal recessive disorder due to deficiency of phenylalanine hydroxylase. Characterized by fair skin, light hair, blue eyes (hypopigmentation), eczema-like rash, microcephaly, hyperactivity, and mild spasticity. Urine has a characteristic “musty” or “mousy” odor due to phenylacetic acid accumulation.
  • Classic Homocystinuria: ((MET083)): Most common inborn error of methionine metabolism, caused by cystathionine beta-synthase deficiency. Features developmental delay, intellectual disability, downward and inward lens dislocation (ectopia lentis) (contrasting with Marfan syndrome which is upward and outward), skeletal findings resembling Marfan, and thromboembolic events; short arms are not characteristic.
  • Maple Syrup Urine Disease (MSUD): ((MET084)): Caused by defect in branched-chain alpha-keto acid dehydrogenase, leading to elevated plasma leucine, isoleucine, and valine. Presents at ~2 weeks with progressive lethargy, muscle rigidity, alternating hypertonia and flaccidity (opisthotonos), and cerebral edema.
  • Hartnup Disease: ((MET077)): Autosomal recessive defect in neutral amino acid transport (SLC6A19 gene), particularly affecting tryptophan. Characterized by pellagra-like photosensitive skin rash and neutral aminoaciduria.
  • Multiple Carboxylase Deficiency: ((MET078)): Defect in biotin metabolism leading to impaired biotin-dependent carboxylases. Presents with seizures, metabolic acidosis with ketosis, normal ammonia, and an erythematous rash over the face and perineum. Treated successfully with high-dose oral biotin (10-20 mg/day). ---

Urea Cycle & Mitochondrial Disorders

  • Urea Cycle Defects (General & OTC Deficiency): ((((MET085)) · ((MET087)) · ((MET088)) · ((MET089)) · ((MET090)))): Term infants present after protein introduction (first feeds) with lethargy, hypotonia, seizures, and markedly elevated blood ammonia.
  • Ornithine Transcarbamylase (OTC) Deficiency: ((((MET088)) · ((MET089)))): X-linked disorder presenting with respiratory alkalosis, hyperammonemia, elevated urinary orotic acid, high glutamine, and low citrulline.
  • Hyperammonemia-Hyperornithinemia-Homocitrullinemia (HHH) Syndrome: ((MET090)): Caused by deficiency of the mitochondrial ornithine transporter (ornithine permease); characterized by hyperammonemia, elevated plasma ornithine, and urinary homocitrulline. - Management ((MET085)): Requires strict dietary protein restriction, high-calorie intake (glucose/lipids to prevent catabolism), sodium phenylacetate/phenylbutyrate, and arginine.
  • Mitochondrial Encephalopathy & Supplements: ((MET074)): Mitochondrial cocktails enhance oxidative phosphorylation and include vitamins (B1, B2, C), antioxidants, and metabolic modifiers (CoQ10, lipoic acid, L-carnitine, folinic acid). Vitamin B12 is not part of the mitochondrial respiratory chain regimen (acts in cytoplasmic methylation and propionate metabolism). ---

Carbohydrate Storage & Glycogen Storage Diseases

  • Hereditary Fructose Intolerance (HFI) vs. Galactosemia: ((MET082)): Both present with failure to thrive, hypoglycemia, vomiting, jaundice, hepatomegaly, renal/hepatic dysfunction, and reducing substances in urine. Impaired intellectual development is characteristic of untreated galactosemia, not HFI.
  • Pompe Disease (GSD Type II): ((MET091)): Caused by deficiency of acid maltase ($\alpha$-1,4-glucosidase), leading to lysosomal glycogen accumulation in cardiac and skeletal muscle. Infantile presentation features hypertrophic cardiomyopathy, massive hepatomegaly, macroglossia, and severe hypotonia. ECG shows short PR interval and high-voltage QRS complexes.
  • Von Gierke Disease (GSD Type I): ((MET101)): Caused by glucose-6-phosphatase deficiency. Presents at 3-4 months with hepatomegaly, hypoglycemic seizures, and persistent hypoglycemia unresponsive to glucagon or epinephrine administration. Children exhibit “doll-like” faces with full cheeks, thin extremities, short stature, and protuberant abdomen. ---

Leukodystrophies & Neurodegenerative Imaging

  • Krabbe Disease: ((MET093)): Caused by galactocerebrosidase (GALC) deficiency. Hallmark MRI feature: Bilateral thalamic hyperintensity ("bright thalami") alongside T2 hyperintensities in deep cerebral white matter.
  • Alexander Disease: ((MET094)): Caused by GFAP mutations leading to Rosenthal fiber accumulation. Hallmark MRI finding: T2-weighted hyperintensities with marked frontal lobe predominance.
  • X-Linked Adrenoleukodystrophy: ((MET095)): Features symmetric demyelination in parietal and occipital white matter. Shows garland contrast enhancement in the parietoccipital region corresponding to perivascular lymphocytic infiltration and blood-brain barrier breakdown (frontal lobe initially spared).
  • Canavan Disease: ((MET096)): Spongy degeneration caused by aspartoacylase deficiency (accumulation of N-acetylaspartic acid [NAA]). Presents with macrocephaly, hypotonia, persistent head lag, optic atrophy, and diffuse symmetrical white matter degeneration on MRI. ---

Fatty Acid Oxidation & Progeria Syndromes

  • Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Deficiency: ((MET097)): Mitochondrial fatty acid oxidation defect affecting C12-C18 fatty acids. Accumulation of toxic lipid intermediates causes retinopathy and cardiomyopathy; fundoscopy reveals bone-spicule pigmentation in the peripheral retina, attenuation of retinal vessels, and optic disc pallor alongside hypoketotic hypoglycemia.
  • Hutchinson-Gilford Progeria Syndrome (HGPS): ((MET098)): Rare sporadic autosomal dominant disorder of accelerated aging caused by mutations in the **LMNA (lamin A)** gene. Features a bird-like face, thin nose, prominent eyes, small jaw, and multiple joint contractures; cognition is not impaired.